| COPD disease stage | ||
---|---|---|---|
 | II | III | IV |
Anthropometrics | Â | Â | Â |
Subjects, n | 21 | 30 | 10 |
Female/male | 10/11 | 10/20 | 5/5 |
Age, yr | 72.0 [59.0–77.0] | 67.5 [61.0–71.0] | 60.5 [52–62] |
BMI (kg/m2) | 28.1 [25.5–32.0] | 24.3 [21.8–28.0] | 20.0 [18.8–20.6] |
Pulmonary functions | Â | Â | Â |
FEV1, L | 1.6 [1.3–1.8] | 1.0 [0.8–1.1] | 0.7 [0.7–0.8] |
FEV1, % predicted | 59.0 [58.0–66.0] | 36.5 [34.0–42.0] | 26.5 [26.0–28.0] |
FEV1/FVC, ratio | 0.6 [0.5–0.6] | 0.4 [0.3–0.5] | 0.4 [0.3–0.4] |
Exercise capacity | Â | Â | Â |
6MWD, m | 370.0 [300.0–438.0] | 352.5 [290.0–392.0] | 345.0 [265.0–374.0] |